A BCC Research Biotechnology Report BIO043D Use this report to: Understand the specific healthcare needs of women and where product development opportunities lie Learn about the primary disorders that afflict primarily women: autoimmune diseases; gynecological diseases, infections, and cancers; kidney and urological diseases and infections; reproductive-related issues; and rheumatoid arthritis and osteoporosis Grasp the evolving demographic and economic factors that will drive future demand for women s therapeutic and diagnostic products Develop business and marketing plans in light of the trends that influence this market. T: 866-285-7215, 1-781-489-7301 F: 781-489-7308 sales@bccresearch.com www.bccresearch.com
Introduction The U.S. market for therapeutics and diagnostics for women s disorders was worth $29.9 billion in 2008. This should increase to $50.0 billion in 2013, for a compound annual growth rate (CAGR) of 10.9%. Women s disorders involve many different areas. The most obvious areas covered under this broad subject are those dealing with reproduction, menstruation, cancer, pregnancy and menopause. However, these are far from the only ones. Female sexuality is markedly different in many ways from male sexuality. Also, several other disorders and diseases are especially prevalent in women such as rheumatoid arthritis, fibromyalgia, systemic lupus erythematosus, osteoporosis and others. New therapeutics and diagnostics have emerged in the last few years that have had a significant impact on women s health. This BCC Research report offers a comprehensive picture of trends in the current U.S. therapeutics and diagnostics for women s disorders industry, and makes market projections over a 5-year period. It covers autoimmune disease, cancer, gynecological diseases and infections, kidney and urological diseases and conditions, reproductiverelated therapeutics and diagnostics, and rheumatoid arthritis and osteoporosis. Therapeutics and diagnostics for women s disorders are analyzed by product category, use of product, market forecast and competitive analysis. The report identifies the disorders/diseases and subcategories; gives brief explanations of the disorders; cites risk factors, incidence and mortality; presents current treatments, market size and market participants; and discusses potential treatments in research and development. Scope of Study The scope of this report is broad and includes: Descriptions of trends that continue to influence the market including the effects of ageing on women s health, contraceptive use and insurance concerns, legislative actions, sexual dysfunction and infertility, and international issues The current U.S. market status for therapeutics and diagnostics for women s disorders, with trends and forecasts for growth over the next 5 years Discussion of government regulatory provisions that govern activities in the industry Company profiles.
Partial Table of Contents The rheumatoid arthritis and osteoporosis segment has the largest share of the market, generating $10.6 billion in 2008. This is expected to grow at a CAGR of 11.5% to reach $18.2 billion in 2013. Chapter One: Introduction Chapter Two: Summary Chapter Three: Industry Overview Definition of Women s Disorders Importance of the Industry and Demographics History of the Industry and Response to Women s Healthcare Needs Regulatory Environment Effects of Aging Contraceptive Insurance Coverage Contraceptive Use in Teens Increases New Use for Contraceptives Aging and Infertility Contraceptive Patch Linked to Deaths Women and Sexual Health Incidence of Sexual Dysfunction Vascular Treatments and Sexual Dysfunction Diagnostics New Developments in Sexual Dysfunction Treatments for Women Sexual Dysfunction in Cancer Infertility and Cancer Chemotherapy Radiation Prevention Strategies Marketing and Women Counterfeit Pharmaceuticals Generic Participation International Issues Chapter Four: Autoimmune Diseases Chronic Fatigue Syndrome Fibromyalgia Myasthenia Gravis Sjogren s Syndrome Systemic Lupus Erythematosus Prestara Ampligen Riquent Chapter Five: Women s Cancers Market by Type of Cancer Breast Cancer Cervical Cancer Endometrial Cancer Ovarian Cancer 572016 Actimmune Arzoxifene Atamestane Faslodex Imc-c2259 Fablyn Ovarex Temsirolimus Theratope Opaxio A Few Select U.S. Products Chapter Six: Gynecological Infections and Sexually Transmitted Diseases Bacterial Vaginosis Candidiasis Cervical Dysplasia Chlamydia Condyloma Dysmenorrhea Endometriosis Fibroids Genital Herpes Pelvic Inflammatory Disease Human Papillomavirus Low Dose Oral Interferon-alpha Chapter Seven: Kidney and Urologic Diseases and Conditions Urinary Tract Infections Urinary Incontinence Urinary Interstitial Cystitis Chapter Eight: Reproductive-Related Therapeutics and Diagnostics Market by Type Contraception Infertility Menopause Bazedoxifene/Conjugated Estrogens Chapter Nine: Rheumatoid Arthritis and Osteoporosis Market by Type Rheumatoid Arthritis Osteoporosis Prexige Remicade Preos Arzoxifene Fablyn U.S. Products Chapter Ten: Market Summary U.S. Women s Healthcare Market Analysis Chapter Eleven: Industry Participants by Type Selected Company Profiles List of Companies 195 pages 44 tables
Selected Tables and Figures Reproductiverelated therapies and diagnostics currently have the second largest market share, worth $5.9 billion in 2008. This should reach $7.5 billion in 2013, for a CAGR of 5.0%. Table 1 Estimates of Anticipated U.S. Life Expectancy at Birth and Projections by Gender, 2000-2020 (Years) Table 3 Projected United States Female Population by Age, Through 2030 (Millions) Table 5 U.S. Sexual Dysfunction Products for Women in Development, 2008 Table 6 U.S. Prescription Generic Drug Approvals for Constraception by Company and Approval Date, 2003 2008 Table 7 U.S. Market Forecast for Autoimmune Diseases by Product Segment, Through 2013 Table 9 U.S. Summary of Autoimmune Disease Market by Competitor Revenues, 2008 Table 10 U.S. Autoimmune Disease Products in Development, 2008 Table 11 U.S. Market Forecast for Women s Cancer by Product Segment, Through 2013 Table 13 Summary of Cancer Market by Competitor Revenues, 2008 Table 14 TNM Classifications of Breast Cancers Table 15 5-year Survival Rate Based on Stage of Breast Cancer for Women in the U.s, 2008 (%) Table 16 Total Yearly Cases and Deaths for Breast Cancer in Women Worldwide, 2008 Table 17 Selected Women s Cancer Products in Development in the U.S., 2008 Table 18 U.S. Gynecological Diseases and Infections Table 19 U.S. Market Forecast for Gynecological Diseases and Infections by Product Segment, Through 2013 Table 20 U.S. Gynecological Diseases and Infections Market by Competitor Table 22 Gynecological Disease and Infection Products in Development in the U.S., 2008 Table 23 U.S. Market Forecast for Kidney and Urological Diseases and Infections by Product Segment, Through 2013 Table 24 U.S. Kidney and Urological Diseases and infection Market by Competitor Revenue, 2008 Table 25 Manufacturers of Kidney and Urologic Disease and Condition Products, 2008 Table 26 U.S. Urinary incontinence/overactive Bladder Market by Competitor Revenue, 2008 Table 27 Kidney and Urological Disease and Conditions Products in Development in the U.S., 2008 Table 28 U.S. Market Forecast for Reproductiverelated by Product Segment, Through 2013 Table 29 U.S. Reproductive-related Therapeutics and Diagnostics Market by Competitor Revenue, 2008 Table 30 Contraceptive Use by Method for U.S. Women Age 15 to 44, by Race, 2002 (Thousands) Table 31 Most Commonly Used Oral Contraceptives in the U.S., 2008 Table 32 U.S. Contraception Market by Competitor Table 33 U.S. infertility Market by Competitor Table 34 Most Commonly Used Menopause Treatment Products 2008 Table 35 U.S. Menopause Market by Competitor Table 36 Reproductive-related Products in Development in the U.S., 2008 Table 37 U.S. Market Forecast for Rheumatoid Arthritis and Osteoporosis by Product Segment, Through 2013 Table 38 U.S. Rheumatoid Arthritis and Osteoporosis Market by Competitor Table 39 Manufacturers of Rheumatoid Arthritis and Osteoporosis Products, 2008 Table 40 U.S. Rheumatoid Arthritis Market by Competitor Table 41 U.S. Osteoporosis Market by Competitor Table 42 Rheumatoid Arthritis and Osteoporosis Products in Development in U.S., 2008 Table 43 U.S. Women s Healthcare Disorder Market Forecast by Segment, Through 2013 Table 44 Major Women s Healthcare industry Participants, by Product Type, 2008 Figure 1 Estimates of Anticipated U.S. Life Expectancy at Birth and Projections by Gender, 2000-2020 (Years) Figure 2 Projected Global Female Population by Age, Through 2030 (Millions) Figure 5 U.S. Summary of Autoimmune Disease Market by Competitor Figure 6 Summary of Cancer Market by Competitor Figure 7 Summary of U.S. Gynecological Diseases and Infections Market by Competitor Revenues, 2008 (%) Figure 8 Summary of Kidney and Urological Diseases and Infection Market by Competitor Figure 9 Summary of U.S. Reproductive-related Market by Competitor Figure 11 Summary of U.S. Rheumatoid Arthritis and Osteoporosis Market by Competitor Revenues, 2008 (%) Figure 12 U.S. Women s Healthcare Disorder Market Forecast by Segment, Through 2013
Related Reports Dermatological Therapeutics: Global Markets ID: HLC057A Published: 01/09 Organ and Tissue Transplantation and Alternatives ID: HLC012D Published: 10/08 Hormone Replacement Therapies and Other Hormone Therapies: Global Markets ID: PHM055A Published: 09/08 More Biotechnology Reports Botanical and Plant-Derived Drugs: Global Markets ID: BIO022E Published: 02/09 Commercial Amino Acids ID: Bio007H Published: 01/09 Biologic Imaging Reagents: Technologies and Global Markets ID: BIO064A Published: 01/09 Protein Drugs: Global Markets and Manufacturing ID: BIO021C Published: 10/08 DNA Sequencing: Emerging Technologies and Applications ID: Bio045B Published: 08/08 DNA Diagnostics: Technologies and Global Markets ID: BIO063A Published: 06/08 About BCC Research BCC Research is a leading publisher of high-quality, technology market research reports and technical publications. BCC Research reports provide quantified measurements of the market and all major industry segments, as well as in-depth analysis of key market drivers and trends. BCC Subscriptions Access hundreds of published reports and automatically receive newly published research with a BCC Report Subscription. We can tailor a complete package of material that meets your needs and budget. BCC Custom Research Improve your strategic planning efforts with a BCC custom research study. We will work with you to determine what information is needed and deliver specific qualitative and quantitative analysis that supports your business objectives. Call 866-285-7215 or 1-781-489-7301 (Intl), or e-mail sales@bccresearch.com for more information about any of BCC Research s products and services. Mail this completed order form to: BCC Research, 40 Washington Street, Wellesley, MA 02481 Fax this completed order form to: 781-489-7308; or place your order by Phone: 866-285-7215 or 1-781-489-7301 E-mail: sales@bccresearch.com Online: www.bccresearch.com Package Discounts are available: Multi-report purchase discounts are available when you order two or more reports. Call 866-285-7215 or 1-781-489-7301 (Intl) for pricing (based on quantity). If using this order form, enter discount and salesperson s initials in the box indicated below. Please send me (please fill in report titles and ID numbers below): ORDER FORM Report ID Title Check format and price below Please choose a payment option: American Express MasterCard Visa CHECK ENCLOSED $ Card No. Exp. Date: / Please make check payable to BCC Research Subtotal CT 6% tax Package Discount/ Sales Rep Signature: Total Name: Title/Department: Company: Address (Include Mail Stop or Bldg. #): City: State/Province: Zip/Postal Code: Country: Phone: Fax: E-mail: Fax or mail to: BCC Research 40 Washington St., Wellesley, MA 02481 To speed your order call (866) 285-7215